Provided by Tiger Fintech (Singapore) Pte. Ltd.

Doximity, Inc.

62.42
+0.37000.60%
Post-market: 62.620.2000+0.32%19:59 EDT
Volume:1.04M
Turnover:64.69M
Market Cap:11.72B
PE:56.23
High:62.55
Open:62.42
Low:61.02
Close:62.05
Loading ...

Doximity Inc. Director Regina M. Benjamin Reports Disposal of Common Shares

Reuters
·
12 Jul

Deutsche Bank Keeps Their Hold Rating on Dr. Martens Plc (DOCS)

TIPRANKS
·
11 Jul

Dr. Martens Reports Steady Trading and Unveils Growth Strategy

TIPRANKS
·
10 Jul

Doximity Shares Rise After Upgrade From Evercore ISI

MT Newswires Live
·
10 Jul

Evercore ISI Upgrades Doximity to Outperform From In Line, Adjusts Price Target to $70 From $50

MT Newswires Live
·
09 Jul

Doximity Raised to Outperform From In-Line by Evercore ISI Group

Dow Jones
·
09 Jul

S&P 500 Futures Up In Premarket Trading; AES, Bloom Energy Lead

Dow Jones
·
09 Jul

Doximity upgraded to Outperform from In Line at Evercore ISI

TIPRANKS
·
09 Jul

Dr. Martens Announces Total Voting Rights Update

TIPRANKS
·
04 Jul

Doximity Inc. Director Kira Scherer Wampler Reports Disposal of Common Shares

Reuters
·
03 Jul

Director Timothy S. Cabral Reports Disposal of Common Shares of Doximity Inc

Reuters
·
28 Jun

Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot?

Zacks
·
26 Jun

Doximity Is Maintained at Neutral by B of A Securities

Dow Jones
·
25 Jun

Doximity price target raised to $62 from $55 at BofA

TIPRANKS
·
25 Jun

Doximity’s Hold Rating: Balancing Optimism with Macroeconomic Caution

TIPRANKS
·
25 Jun

Dr. Martens Plc (DOCS) Receives a Hold from Goldman Sachs

TIPRANKS
·
21 Jun

Potential Regulatory Changes in Pharmaceutical Advertising Boost Doximity’s Prospects

TIPRANKS
·
19 Jun

Dr. Martens Releases 2025 Annual Report and AGM Notice

TIPRANKS
·
17 Jun

Doximity Co-Founder Steps Down to Advisory Role

TIPRANKS
·
14 Jun

Doximity Inc. Announces Leadership Transition as Co-Founder Dr. Nate Gross Steps Down from Day-to-Day Role, Remains as Advisor

Reuters
·
14 Jun